MyFinsight
Home
Blog
About
Contact
Download
Download image
Commercialization revenue
$120,772K
(-6.33%↓ Y/Y)
Total revenue
$120,772K
(-6.33%↓ Y/Y)
Loss from operations
$35,862K
(142.98%↑ Y/Y)
Total costs and
operating expenses
$84,910K
(-60.02%↓ Y/Y)
Loss before
provision for (benefit...
$32,719K
(138.31%↑ Y/Y)
Total other income
(expense), net
-$3,143K
(-58.98%↓ Y/Y)
Interest income
$683K
(-67.63%↓ Y/Y)
Research and development
expenses
$37,445K
(-75.28%↓ Y/Y)
General and
administrative expenses
$26,253K
(-34.18%↓ Y/Y)
Cost of
commercialization revenue
$21,212K
(0.97%↑ Y/Y)
Net loss
$32,688K
(138.28%↑ Y/Y)
Provision for (benefit
from) income taxes
$31K
(358.33%↑ Y/Y)
Interest expense
$3,792K
(-17.83%↓ Y/Y)
Other income
(expense), net
-$34K
(-106.44%↓ Y/Y)
Comprehensive loss
$32,681K
(138.36%↑ Y/Y)
Unrealized gain (loss) on
available-for-sale securities
-$7K
(-103.30%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Atara Biotherapeutics, Inc. (ATRA)
Atara Biotherapeutics, Inc. (ATRA)